LLAI Share Price Performance
UK£0.042
0.03 (361.11%)
Price UK£0.042
Share Pricen/a
LungLife AI, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
LLAI Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
LungLife AI, Inc. Key Details
Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
- -0.15
- 100.00%
- -15,403.45%
- 0%
About LLAI
- Founded
- 2009
- Employees
- 8
- CEO
- WebsiteView website
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.
